SCHEMBL80165

SCHEMBL80165

CCOC(=O)C(CC(N)=O)(CC(=O)c1ccc(OC)c(C(F)(F)F)c1)C(=O)OCC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.45
THRA P10827 1/20 0.40
THRB P10828 1/20 0.40
MAPT P10636 3/20 0.40
CTNNB1 P35222 2/20 0.40
WNT3A P56704 2/20 0.40
TSHR P16473 1/20 0.40
MAPK1 P28482 1/20 0.40
KMT2A Q03164 3/20 0.39
CYP2C19 P33261 2/20 0.39
MEN1 O00255 2/20 0.39
KDM4E B2RXH2 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
HTT P42858 1/20 0.39
POLB P06746 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
BRAF P15056 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
ROCK2 O75116 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL86769 0.85 ALDH1A1 (0.47) ALDH1A1THRATHRBMAPTCTNNB1
SCHEMBL80695 0.81 S1PR1 (0.42) KDM4EGAALMNA
SCHEMBL2463688 0.80 ALDH1A1 (0.44) ALDH1A1THRATHRBMAPTMAPK1
SCHEMBL14776123 0.78 HSD17B2 (0.60) ALDH1A1MAPTTSHRMAPK1KMT2A
SCHEMBL80164 0.76 THRA (0.41) ALDH1A1THRATHRBTSHRKMT2A
SCHEMBL628125 0.74 MAPK1 (0.54) ALDH1A1MAPTTSHRMAPK1KMT2A
SCHEMBL12336977 0.73 THRA (0.45) ALDH1A1THRATHRBMAPTCTNNB1
SCHEMBL81878 0.73 GSK3B (0.50) ALDH1A1THRATHRBMAPTCTNNB1
Hydrochloric Acid SCHEMBL7840484 0.73 MAPK1 (0.53) ALDH1A1MAPTTSHRMAPK1KMT2A
SCHEMBL21176907 0.73 THRA (0.46) ALDH1A1THRATHRBMAPTCTNNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2168944-B1 AMINE COMPOUND AND PHARMACEUTICAL USE THEREOF MITSUBISHI TANABE PHARMA CORP (JP) 2016-05-11 EP disclosed
US-8129361-B2 Amine compound and pharmaceutical use thereof MITSUBISHI TANABE PHARMA CORPORATION (JP) 2012-03-06 US disclosed
US-20100179216-A1 AMINE COMPOUND AND PHARMACEUTICAL USE THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-07-15 US disclosed
EP-2168944-A1 AMINE COMPOUND AND PHARMACEUTICAL USE THEREOF Mitsubishi Tanabe Pharma Corporation (JP) 2010-03-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100179216-A1 AMINE COMPOUND AND PHARMACEUTICAL USE THEREOF HLA-B, HLA-A, HLA-C ALDH1A1 646/4885THRA 1980/4885THRB 1455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.